AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $86.61 million versus the consensus estimate of $80.24 million.

GUIDANCE:

AngioDynamics sees FY2027 EPS of ($0.29)-$0.24, versus the consensus of ($0.20). AngioDynamics sees FY2027 revenue of $336-341 million, versus the consensus of $314 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.